Mesenchymal stem cells respond with enhanced trophic factor secretion, including dose-dependent increases in VEGF and bFGF
This finding was further supported by the SELECT trial, which showed a 20% reduction in 3-point major adverse cardiovascular events (MACE) in people with obesity but without diabetes
It is not evidence that tesamorelin causes general weight loss, builds muscle, improves body composition in healthy adults, or delivers anti-aging benefits
The medication is already in liquid form, the dose mechanism is built in, and the process requires minimal preparation
The combination produces gradual softening of expression lines over several months of use
They help to reduce oxidative stress, which can lead to skin damage and aging